Regen Biopharma, Inc.

$rgbp Chart Analysis

146
upon review bullish divergence can be seen when combining rsi with price action
mac d is coming to retest

candles give off sign we''ve hit the bottom

huge buy of 30k today

descending triangle spotted that may break up or down

The Barchart Technical Opinion rating is a 72% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

be careful trading against trends

免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。